Princeton, New Jersey, April 25, 2012 – Sandoz today announced the introduction of enoxaparin sodium injection, USP 3 mL vials, a generic version of Sanofi's Lovenox® Injection Multiple-Dose Vials, in ...
The combined use of anticoagulants, antiplatelet agents, and invasive coronary procedures reduces ischemic coronary events but also increases bleeding in patients with acute coronary syndromes. We ...
Preliminary studies have suggested that fondaparinux could be just as effective as enoxaparin in preventing ischemic events, and safer than unfractionated heparin in terms of bleeding, in patients ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results